Cargando…
P1359: TUMOR-SPECIFIC, T-CELL-TARGETING MICRORNA IS ASSOCIATED WITH CART CELL FAILURE IN B CELL MALIGNANCIES
Autores principales: | Chohan, Karan, Sirpilla, Olivia, Leo Sakemura, R., Cox, Michelle, Hefazi, Mehrdad, Huynh, Truc, Girsch, James, Schick, Kendall, Manriquez Roman, Claudia, Stewart, Carli M., Yun, Kun, Can, Ismail, Ogbodo, Ekene J., Mai, Long, Kimball, Brooke, Ansell, Stephen M., Nora Bennani, N., Johnston, Patrick B., Paludo, Jonas, Villasboas-Bisneto, Jose C., Khurana, Arushi, Durani, Urshila, Wang, Yucai, Hampel, Paul J., Rosenthal, Allison, Munoz, Javier, Moreno, Eider, Castro, Januario E., Murthy, Hemant S., Kharfan Dabaja, Mohamed, Parikh, Sameer, Kay, Neil, Lin, Yi, Siegler, Elizabeth L., Kenderian, Saad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430677/ http://dx.doi.org/10.1097/01.HS9.0000972324.07303.db |
Ejemplares similares
-
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
por: Kankeu Fonkoua, Lionel A., et al.
Publicado: (2022) -
Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma
por: Acosta-Medina, Aldo A., et al.
Publicado: (2023) -
In vivo CART cell imaging: Paving the way for success in CART cell therapy
por: Sakemura, Reona, et al.
Publicado: (2021) -
Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients
por: Powell, Marissa Z., et al.
Publicado: (2023) -
Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy
por: Bezerra, Evandro D., et al.
Publicado: (2022)